龙灯瑞迪制药WeChat
龙灯瑞迪制药
龙灯瑞迪制药 Language
龙灯瑞迪制药
EN CN
Dasatinib Tablets
Dasatinib Tablets
Products Name:Dasatinib Tablets
Trade Name: 瑞佑®
Indications: This product is indicated for the treatment of adult patients with Philadelphia chromosome positive (Ph+) chronic myeloid leukemia (CML) in chronic phase, accelerated phase, or blast phase (myeloid blast crisis and lymphoid blast crisis) who are resistant to or intolerant of imatinib mesylate.
Strength: 20mg,50 mg
Approval Number: National Drug Approval No. HJ20240086,National Drug Approval No. HJ20240085
View Package Insert
This content is only available to healthcare professionals. Non professionals can click 'Cancel'
Cancel
Confirm